https://orcid.org/0000-0001-9089-4789
References
- Centro Nacional de Epidemiología (CNE), Ministerio de Sanidad de España. National center of epidemiology, ministry of health, Spain [Internet] [cited 2020 Oct 5]. Available from: https://cnecovid.isciii.es/covid19/#declaración-agregada
- Piñana JL, Martino R, García-García I, et al. Risk factors and outcome of COVID-19 in patients with hematological malignancies. Exp Hematol Oncol. 2020 [cited 2020 Oct 9]: [16p.]. 9:21.
- Ljungman P, Mikulska M, de la Camara R, et al. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplant. 2020 [ update 2020 Jun 8; cited 2020 Oct 5]: [6p.]. DOI:10.1038/s41409-020-0919-0.
- Brissot E, Labopin M, Baron F, et al. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2020 [cited 2020 Oct 9]: [4p.]. DOI:10.1038/s41409-020-0970-x.
- Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO). Recomendaciones del Comité Científico del grupo GELTAMO para el manejo de los pacientes con linfoma durante la crisis del Covid-19. [Recommendations from the scientific committee of the GELTAMO group for managing patients with lymphoma during COVID-19 outbreak] [Internet] Spanish. [cited 2020 Oct 5]. Available from: https://www.geltamo.com/images/PDF/Recomendaciones%20linfomas%20Covid-19%2019%20MARZO%202020.pdf
- Terpos E, Engelhardt M, Cook G, et al. Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia. 2020;34(8):2000–2011. .
- Sahu KK, Cerny J. Managing patients with hematological malignancies during COVID-19 pandemic [published online ahead of print, 2020 Jul 12]. Expert Rev Hematol. 2020;13(8):787–793.
- Xu Z‐L, Huang X‐J. COVID‐19 & allogeneic transplant: activity and preventive measures for best outcomes in China. Adv Cell Gene Ther. 2020; [cited 2020 Oct 9]: [4p.];3. DOI:10.1002/acg2.94.
- Balduzzi A, Brivio E, Rovelli A, et al. Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Bone Marrow Transplant. 2020;55:1900–1905.
- Algwaiz G, Aljurf M, Koh M, et al. WBMT and the CIBMTR Health Services and International Studies Committee. Real-world issues and potential solutions in hematopoietic cell transplantation during the COVID-19 pandemic: perspectives from the worldwide network for blood and marrow transplantation and center for international blood and marrow transplant research health services and international studies committee. Biol Blood Marrow Transplant. 2020 [cited 2020 Oct 9]: [9p.]. DOI:10.1016/j.bbmt.2020.07.021.
- Organización Nacional de Trasplantes (ONT), Ministerio de Sanidad. Spanish recommendations to manage organ donation and transplantation regarding the infection associated with the new coronavirus (SARS-CoV-2) producer of COVID-19 (extract from the biovigilance alert reference BV-ES-20200122- last update 13 April 2020) [Internet]. [cited Oct 5]. Available from: http://www.ont.es/infesp/RecomendacionesParaProfesionales/Spanish%20Recommendations%20on%20Organ%20Donation%20and%20Transplantation%20COVID-19%20%20ONT.pdf
- World Marrow Donor Association. COVID-19 impact on registry operations. [Internet]. [cited Oct 9]. Available from: https://share.wmda.info/display/LP/COVID-19+-+Impact+on+Registry+Operations#/
- Kissler SM, Tedijanto C, Goldstein E, et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.Science. 2020;368(6493):860–868.
- Di Ciaccio P, McCaughan G, Trotman J, et al. Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic. Intern Med J. 2020;50(6):667–679. .
- Perini GF, Fischer T, Gaiolla RD, et al. How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation. Hematol Transfus Cell Ther. 2020;42(2):103–110. .
- Varma A, Kosuri S, Ustun C, et al. COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter. Leukemia. 2020;34(10):2809–2812.
- Niu A, McDougal A, Ning B, et al. COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma. Bone Marrow Transplant. 2020 [cited Oct 5]: [3p.];55:2354–2356.